Form D — Ikena Oncology, Inc.
0001470831-25-000095 · filed 2025-07-18
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $75,000,000
- Total sold
- $0
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ikena Oncology, Inc.
- CIK
- 1835579
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 645 Summer Street, Suite 101
BOSTON, MA 02210 - Phone
- 857-273-8343
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Mark Manfredi · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Jotin Marango · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Jeffrey Ecsedy · Executive OfficerBoston, MA Find on LinkedIn ↗
-
David Bonita · DirectorBoston, MA Find on LinkedIn ↗
-
Iain Dukes · DirectorBoston, MA Find on LinkedIn ↗
-
Jean-Francois Formela · DirectorBoston, MA Find on LinkedIn ↗
-
Otello Stampacchia · DirectorBoston, MA Find on LinkedIn ↗
-
Maria Koehler · DirectorBoston, MA Find on LinkedIn ↗
-
Richard Wooster · DirectorBoston, MA Find on LinkedIn ↗
-
Owen Hughes · DirectorBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.